Paper39679205
Treatment outcomes in NTM-PD in a high TB burden context.
Kang S and 3 others. IJTLD Open, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Treatment outcomes in NTM-PD in a high TB burden context. Papers, record 39679205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39679205
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33926548 | Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey. | Infect Dis Poverty | 2021 | https://conductscience.org/library/papers/33926548 | PubMed |
| 2 | 32070324 | Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016. | BMC Pulm Med | 2020 | https://conductscience.org/library/papers/32070324 | PubMed |
| 3 | 32636299 | Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. | Eur Respir J | 2020 | https://conductscience.org/library/papers/32636299 | PubMed |
| 4 | 32814943 | Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management. | J Infect Dis | 2020 | https://conductscience.org/library/papers/32814943 | PubMed |
| 5 | 33333637 | [Guidelines for bronchial asthma prevent and management(2020 edition) Asthma group of Chinese Throacic Society]. | Zhonghua Jie He He Hu Xi Za Zhi | 2020 | https://conductscience.org/library/papers/33333637 | PubMed |
| 6 | 25614169 | The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease. | Eur Respir J | 2015 | https://conductscience.org/library/papers/25614169 | PubMed |
| 7 | 33832019 | [Expert consensus on the diagnosis and treatment of adult bronchiectasis in China]. | Zhonghua Jie He He Hu Xi Za Zhi | 2021 | https://conductscience.org/library/papers/33832019 | PubMed |
| 8 | 30687747 | In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/30687747 | PubMed |
| 9 | 29567726 | Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. | Eur Respir J | 2018 | https://conductscience.org/library/papers/29567726 | PubMed |
| 10 | 32527504 | Treatment for Mycobacterium abscessus complex-lung disease. | J Formos Med Assoc | 2020 | https://conductscience.org/library/papers/32527504 | PubMed |
| 11 | 12709349 | In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/12709349 | PubMed |
| 12 | 32870060 | Summary for Clinicians: 2020 Clinical Practice Guideline Summary for the Treatment of Nontuberculous Mycobacterial Pulmonary Disease. | Ann Am Thorac Soc | 2020 | https://conductscience.org/library/papers/32870060 | PubMed |
| 13 | 34390707 | Outcomes of Resectional Thoracic Surgery for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease in 105 Patients in the United States. | Chest | 2022 | https://conductscience.org/library/papers/34390707 | PubMed |
| 14 | 30880280 | M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis. | Eur Respir J | 2019 | https://conductscience.org/library/papers/30880280 | PubMed |
| 15 | 33782057 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. | BMJ | 2021 | https://conductscience.org/library/papers/33782057 | PubMed |
| 16 | 17277290 | An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. | Am J Respir Crit Care Med | 2007 | https://conductscience.org/library/papers/17277290 | PubMed |
| 17 | 30071548 | Geographic Distribution of Nontuberculous Mycobacteria Isolated from Clinical Specimens: A Systematic Review. | Semin Respir Crit Care Med | 2018 | https://conductscience.org/library/papers/30071548 | PubMed |
| 18 | 32617011 | Antimicrobial Susceptibility of Mycobacterium abscessus Complex Clinical Isolates from a Chinese Tertiary Hospital. | Infect Drug Resist | 2020 | https://conductscience.org/library/papers/32617011 | PubMed |
| 19 | 31506134 | Prevalence and risk factors of pulmonary nontuberculous mycobacterial infections in the Zhejiang Province of China. | Epidemiol Infect | 2019 | https://conductscience.org/library/papers/31506134 | PubMed |
| 20 | 33839127 | Outcomes of Surgical Treatment for Mycobacterium abscessus Complex Pulmonary Disease. | Ann Thorac Surg | 2022 | https://conductscience.org/library/papers/33839127 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42064296 | Predictive Value of Nutritional Status in Sputum Culture Conversion Among Patients with Nontuberculous Mycobacterial Pulmonary Disease: A Retrospective Cohort Study. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/42064296 | PubMed |
| 41994466 | Development and internal validation of a LASSO-based clinical prediction model for nontuberculous mycobacterial pulmonary disease versus pulmonary tuberculosis. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41994466 | PubMed |
| 41843721 | Real-World Experience of Prolonged Treatment for Treatment-Refractory Nontuberculous Mycobacterial Pulmonary Disease: Benefits and Harms of Extending Therapy beyond 24 Months. | Respiration | 2026 | https://conductscience.org/library/papers/41843721 | PubMed |
| 41244776 | Case Report: First pulmonary infection caused by Mycobacterium colombiense in a non-immunosuppressed host with bronchiectasis: diagnosis facilitated by synergistic mNGS and culture. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41244776 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39679205
GET https://conductscience.org/api/papers/v1/39679205/references?page=2